Almonertinib-induced interstitial lung disease: A case report

RATIONALE: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have elicited favorable anti-tumor activity in non-small cell lung cancer especially the lung adenocarcinoma. Interstitial lung disease (ILD) is 1 of the fatal side effects of EGFR-TKIs. However, such type of side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ting, Luo, Yiyang, Wang, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837903/
https://www.ncbi.nlm.nih.gov/pubmed/33546082
http://dx.doi.org/10.1097/MD.0000000000024393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837903/
https://www.ncbi.nlm.nih.gov/pubmed/33546082
http://dx.doi.org/10.1097/MD.0000000000024393

Ejemplares similares